Tuesday, March 2 - 8:00 a.m. - 8:50 a.m.

Regulatory Issues Facing the Retail and Pharmaceutical Supply Chain
Breakout Rooms 3/5, Level 3
Presentation 1
Presentation 2

Supply chain security will be an area of focus for the FDA in 2010. This session will feature the FDA presenting their new focus on the impact of cargo theft of pharmaceutical products and OTC medicines on the health and safety of the American consumer. Additionally, the session will also provide an update on the FDA's actions as they relate to the implementation of section 505D of the FDAAA of 2007 which calls for the FDA to issue standards for a Standardized Numerical Identifier as well as standards for track and trace and other anti-counterfeiting technologies.

Dr. Ilisa Bernstein
Director of Pharmacy Affairs and Acting Director of the Policy Department and Coordination Staff in the Office of the Commissioner
U.S. Food and Drug Administration
 

Best Practices in European Supply Chain Operations
Breakout Rooms 4/6, Level 3
Presentation

One area that supply chain executives look to in order to determine "what's next" in supply chain improvement is how companies are managing their supply chain in Europe. In this session participants will hear about what is happening now in the European supply chain that American businesses should be thinking about including collaboration, material handling, network design and sustainability.

Simon Ellis
Practice Director, Supply Chain Strategies
Manufacturing Insights

Returns - Improving Practices for both Pharmaceuticals and CPG
Breakout Rooms 9/11, Level 3
Presentation

Over the past twelve months two studies have been looking at returns for both pharmaceutical products as wells consumer packaged goods to understand how to minimize the size of returns as well as streamlining the returns process. This session will feature the author of these two studies as he discusses their results and the similarities and differences between the two returns processes.

Dan Raftery
President
Raftery Resources Network
 

9:00 a.m. - 9:50 a.m. - Breakout Sessions

Food & Drug Traceability: Will the Standards/Processes be Compatible?
Breakout Rooms 3/5, Level 3
Presentation

2010 will be a big year for traceability in both the food and drug supply chains. The FDA is actively pursuing multiple tracks to enhance the safety of both supply chains - albeit for different reasons. This session will highlight efforts by GS1 US to develop standards for both industries in product traceability. We will hear how their efforts are progressing and to what extent the processes and technologies that companies will put in place will be able to be leveraged across both product categories.

Steve Arens
Director, Industry Development
GS1 US

Bob Celeste
Director, Healthcare
GS1 US

Sustainability - How One Company Achieved Zero Landfill Status
Breakout Rooms 4/6, Level 3
Presentation

Taking a good idea, harnessing the power of your people and collaborating with your vendors is the formula for success. In this session, our speaker will describe how his company used that formula to significantly reduce their carbon footprint in their community and the benefits that his company derived.

Bob Bredbenner
Logistics Manager
Unilever

CPSIA Certificate Exchange Program - Simplifying Compliance, Saving Resources
Breakout Rooms 9/11, Level 3
Presentation

In August, 2008, President Bush signed the CPSIA into law. One of the regulations requires manufacturers of products that are regulated by the Consumer Product Safety Commission, CPSC to pass general certificates of conformity to retailers and distributors with each shipment. This session will highlight a solution that has been developed by NACDS in conjunction with our technology partner; RollStream can be leveraged by both retailers and manufacturers to make compliance easy and affordable.

Kristin Muhlner
Chief Operating Officer
RollStream